The upgrade reflects the dramatic improvement in the cancer center’s unrestricted liquidity and growth in cash. The rating favorably reflects the organization’s national standing as a leading cancer research institute.
The rating outlook is stable.
More articles on healthcare finance:
Bankrupt hospital chain’s plan to offload 5 California clinics faces opposition
Attorney general investigating 2 Kansas hospitals that abruptly closed
Trinity Health posts $301M loss in first half of fiscal year
